Africa & Middle East

This strategic shift addresses mounting concerns about regulatory compliance and workforce development in the country’s healthcare sector.

The Pharmacy and Poisons Board has approved both the 300 mg tablet and 464 mg injectable solution forms of Lenacapavir for use as pre-exposure prophylaxis (PrEP).

This cutting-edge approach represents a major advancement in how doctors can treat genetic diseases by directly modifying the faulty genes responsible for these conditions.

This approach will help ensure that the local manufacturing of diagnostic imaging equipment remains economically viable and financially sustainable over the coming years.

Dr. Kays, who previously served JOOTRH as an obstetrician-gynecologist, returns after completing two years of specialized training in maternal-fetal medicine.

With a capacity exceeding 300 beds, the hospital will deliver both primary and secondary healthcare services to citizens and residents throughout the wilayat and surrounding areas.

Antimicrobial resistance (AMR) develops when bacteria, viruses, and fungi evolve to resist medications, making infections harder to treat and increasing the risk of severe illness and death.

Before this partnership, JOOTRH referred radiotherapy cases to Kenyatta National Hospital (KNH) or Moi Teaching and Referral Hospital (MTRH).

Phenylketonuria (PKU) affects approximately one in 23,930 newborns globally, with higher prevalence in parts of Europe and the Middle East.

Researchers surveyed nearly 5,000 women between ages 45 and 60 across four Mayo Clinic primary care locations.